CES1
protein-codingcarboxylesterase 1, the group of Carboxylesterases
Gene summary
This gene encodes a member of the carboxylesterase large family. The family members are responsible for the hydrolysis or transesterification of various xenobiotics, such as cocaine and heroin, and endogenous substrates with ester, thioester, or amide bonds. They may participate in fatty acyl and cholesterol ester metabolism, and may play a role in the blood-brain barrier system. This enzyme is the major liver enzyme and functions in liver drug clearance. Mutations of this gene cause carboxylesterase 1 deficiency. Three transcript variants encoding three different isoforms have been found for this gene. [provided by RefSeq, Jun 2010]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~30.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
Clinical Genomic Database (CGD)
Manifestation: Biochemical
Intervention: Pharmacogenomic
Rationale: Selection and dosing of certain medications may be affected by the presence of variants
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CES1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001025195.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 5 | 6 | |||
| missense | 1 | 96 | 10 | 107 | ||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | 2 | |||
| splice donor/acceptor (+/-2bp) | 4 | 4 | ||||
| Total | 2 | 0 | 102 | 15 | 0 | 119 |
Highest pathogenic variant AF is 0.000037756698
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001020366.1 | 14 | MANE Select | |
| Ensembl | ENSP00000353720.4 | 14 | MANE Select | |
| RefSeq | NP_001020365.1 | 14 | Standard | |
| RefSeq | NP_001257.4 | 14 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Drug metabolism - other enzymes - Homo sapiens (human)
- Fluoropyrimidine Pathway, Pharmacokinetics
- Clopidogrel Pathway, Pharmacokinetics
- Mycophenolic acid Pathway, Pharmacokinetics
- Mycophenolic acid Pathway, Pharmacokinetics/Pharmacodynamics
Biological Process
- cholesterol biosynthetic process
- xenobiotic metabolic process
- response to toxic substance
- lipid catabolic process
- epithelial cell differentiation
Molecular Function
- sterol esterase activity
- triglyceride lipase activity
- methylumbelliferyl-acetate deacetylase activity
- carboxylic ester hydrolase activity
Cellular Component
- extracellular space
- endoplasmic reticulum
- endoplasmic reticulum lumen
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000360526
- Coding exons
- 14
- Length
- 30487
- Individuals with no LoFs
- 118876
- Homozygous LoFs
- 6
- Heterozygous LoFs
- 6866
- Defined
- 125748
- p
- 0.0277
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -2.00 | 307 | 223 | 1.38 | 0.0000124 | 3604 |
| Missense (PolyPhen) | 98 | 72.254 | 1.3563 | 1185 | ||
| Synonymous | -3.37 | 130 | 89.4 | 1.45 | 0.00000543 | 1103 |
| Loss of Function | -0.0859 | 22 | 21.6 | 1.02 | 0.00000112 | 319 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.015 | 0.015 | notable |
| Latino/Admixed American | 0.047 | 0.047 | notable |
| Ashkenazi Jewish | 0.022 | 0.023 | notable |
| East Asian | 0.063 | 0.064 | notable |
| Finnish | 0.011 | 0.011 | notable |
| European (Non-Finnish) | 0.017 | 0.017 | notable |
| South Asian | 0.043 | 0.043 | notable |
| Other | 0.029 | 0.029 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Involved in the detoxification of xenobiotics and in the activation of ester and amide prodrugs. Hydrolyzes aromatic and aliphatic esters, but has no catalytic activity toward amides or a fatty acyl-CoA ester. Hydrolyzes the methyl ester group of cocaine to form benzoylecgonine. Catalyzes the transesterification of cocaine to form cocaethylene. Displays fatty acid ethyl ester synthase activity, catalyzing the ethyl esterification of oleic acid to ethyloleate. {ECO:0000269|PubMed:7980644, ECO:0000269|PubMed:9169443}.;
Recessive Scores
- pRec
- 0.333
Intolerance Scores
- LoFtool
- 0.954
- RVIS EVS
- 1.91
- RVIS percentile EVS
- 97.43
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.988
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |